n CME : Your SA Journal of CPD - Pharm info

Volume 22, Issue 3
  • ISSN : 0256-2170



Extracted from text ... Patients taking Pfizer Inc's cholesterol-lowering medicine Lipitor (atorvastatin calcium) experienced a significant reduction in the progression of atherosclerosis compared with patients who received Prava (pravastatin), according to new data presented at the annual meeting of the American Heart Association in Orlando, Florida, in November 2003. The Reversing Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) study followed up 502 patients who were diagnosed with coronary heart disease and required cardiac catheterisation or angiograms. Patients in the 18- month study had at least one arterial vessel with 20% or more constriction due to plaque build-up. The study compared the effectiveness of Lipitor (80 ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error